An observational study in Hemodialysis and Malnutrition, sponsored by University of Shizuoka. Status unknown at 1 site in Japan. Open to participants aged 0 Years to 70 Years. Per ClinicalTrials.gov, last updated 2006-05-22.
Sponsored by University of Shizuoka · Observational
The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.
Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.
1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.
This study's enrollment of 300 is above the median of 203 across 388 observational studies indexed under Malnutrition.
Browse Malnutrition studies →University of Shizuoka is the lead sponsor of 11 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This study is status unknown, as verified in Mar 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Shizuoka